SCHEMBL29327675

SCHEMBL29327675

Cc1cccc(-c2nc3cc(NC(=O)c4cc(C#N)ccc4S(=O)(=O)C(F)(F)F)ccc3o2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.55
▸ THRB P10828 2/20 0.55
▸ RXFP1 Q9HBX9 4/20 0.54
▸ TP53 P04637 3/20 0.54
▸ KDM4E B2RXH2 4/20 0.53
▸ NPC1 O15118 4/20 0.53
▸ RAB9A P51151 4/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ HPGD P15428 3/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ PPARG P37231 3/20 0.53
▸ LMNA P02545 2/20 0.49
▸ GLA P06280 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ CETP P11597 3/20 0.47
▸ STAT3 P40763 1/20 0.47
▸ STAT1 P42224 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29327577 0.92 MAPT (0.58) MAPTTHRBRXFP1TP53KDM4E
SCHEMBL29327677 0.91 PPARG (0.59) MAPTTHRBRXFP1TP53KDM4E
SCHEMBL29327687 0.91 PPARG (0.55) MAPTTHRBRXFP1TP53KDM4E
SCHEMBL29327701 0.91 PPARG (0.55) MAPTRXFP1TP53KDM4ENPC1
SCHEMBL29327681 0.86 MAPT (0.55) MAPTRXFP1TP53NPC1RAB9A
SCHEMBL29327683 0.86 PPARG (0.72) MAPTRXFP1TP53SMN1; SMN2PPARG
SCHEMBL29327696 0.85 TP53 (0.56) MAPTTHRBRXFP1TP53KDM4E
SCHEMBL29327692 0.83 MAPT (0.54) MAPTTHRBRXFP1TP53KDM4E
SCHEMBL29327588 0.83 PPARG (0.59) MAPTTHRBRXFP1TP53KDM4E
SCHEMBL29327596 0.83 PPARG (0.57) MAPTTHRBRXFP1TP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239760-A1 PPARG INVERSE AGONISTS AND USES THEREOF FLARE THERAPEUTICS INC. 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239760-A1 PPARG INVERSE AGONISTS AND USES THEREOF PPARG, PPARA, PPARD MAPT 4591/4885THRB 89/4885RXFP1 286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback